ISRCTN15459149
Active, not recruiting
未知
Bladder cancer molecular subtypes in clinical practice (UROSCANSEQ)
Skåne University Hospital0 sites20,000 target enrollmentFebruary 18, 2019
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- rothelial carcinoma of the urinary bladder
- Sponsor
- Skåne University Hospital
- Enrollment
- 20000
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Bladder cancer subjected to transurethral resection of the tumour (TURB)
Exclusion Criteria
- •Does not meet inclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Molecular diagnostics of bladder cancer.bladder cancerurothelial carcinoma1003836410004994NL-OMON30884Erasmus MC, Universitair Medisch Centrum Rotterdam30
Not yet recruiting
Not Applicable
Tumor Staging T of Bladder Tumours: Correlation of MRI and Anatomopathologic AnalysisUrinary Bladder TumourMRIInvasionDiagnosisNCT05464576University Hospital, Clermont-Ferrand150
Completed
Not Applicable
Basal Tumours in Bladder Cancer, Response to chemoTherapyBladder CancerChemotherapy EffectNCT04089748University Hospital, Rouen293
Active, not recruiting
Not Applicable
Molecular Analysis Of Bladder CancerBladder CancerBladder NeoplasmsNCT00871754Lahey Clinic5,000
Active, not recruiting
Not Applicable
Molecular Studies and Clinical Correlations in Human Prostatic DiseaseProstate CancerNCT00578240Memorial Sloan Kettering Cancer Center5,290